Literature DB >> 3494621

Binding of [125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium.

M R Dashwood, H E Andrews, E T Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3494621     DOI： 10.1016/0014-2999(87)90766-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  5 in total

1.  Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.

Authors:  D M Barker; R Corder
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Relaxing actions of corticotropin-releasing factor on rat resistance arteries.

Authors:  S Lei; R Richter; M Bienert; M J Mulvany
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone.

Authors:  A Kübler; G Rothacher; V A Knappertz; G Krämer; M Nink; J Beyer; H Lehnert
Journal:  Clin Investig       Date:  1994-05

4.  Differential expression of a cutaneous corticotropin-releasing hormone system.

Authors:  Andrzej Slominski; Alexander Pisarchik; Desmond J Tobin; Joseph E Mazurkiewicz; Jacobo Wortsman
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

5.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.